Quantbot Technologies’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Sell
5,455
-3,363
-38% -$306K 0.02% 908
2026
Q1
$849K Buy
8,818
+1,425
+19% +$143K 0.03% 652
2025
Q4
$719K Buy
7,393
+5,084
+220% +$436K 0.02% 791
2025
Q3
$164K Buy
+2,309
New +$154K ﹤0.01% 1349
2025
Q2
Sell
-1,486
Closed -$78K 1776
2025
Q1
$78K Buy
+1,486
New +$83.5K ﹤0.01% 1272
2024
Q4
Sell
-2,320
Closed -$117K 1651
2024
Q3
$117K Buy
2,320
+1,052
+83% +$48.5K ﹤0.01% 1150
2024
Q2
$55.7K Sell
1,268
-530
-29% -$22.5K ﹤0.01% 1231
2024
Q1
$79.1K Buy
1,798
+454
+34% +$20.1K ﹤0.01% 1251
2023
Q4
$63.8K Buy
1,344
+137
+11% +$5.76K ﹤0.01% 1291
2023
Q3
$53.6K Buy
1,207
+94
+8% +$4.37K ﹤0.01% 1235
2023
Q2
$53.1K Buy
+1,113
New +$50.2K ﹤0.01% 1307
2022
Q2
Sell
-2,639
Closed -$118K 1903
2022
Q1
$118K Buy
+2,639
New +$122K 0.01% 999

Other funds holding IRMD

Quantbot Technologies's IRMD Position: Q2 2026 in Review

Quantbot Technologies reduced its iRadimed (IRMD) stake by 38% in Q2 2026, selling an estimated $306K and leaving 5,455 shares worth $521K. The position accounts for 0.02% of the portfolio, ranked #908.

Quantbot Technologies first reported a position in IRMD in Q1 2022 and has held it in 12 quarters since. The position peaked at $849K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Quantbot Technologies held 5,455 shares of iRadimed worth $521K as of Q2 2026.
  • Quantbot Technologies sold 3,363 iRadimed shares in Q2 2026, an estimated $306K.
  • iRadimed made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #908 holding.
  • Quantbot Technologies first reported a position in iRadimed in Q1 2022 and has held it in 12 quarters since.
  • Quantbot Technologies's iRadimed position peaked at $849K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.